Announcements Trials
Browse Landscape

Phase

Phase NA 43Phase 2 41Phase 1 23Phase 3 13Phase 4 7Phase 1/2 7Phase EARLY_PHASE1 5Phase 2/3 2

Status

Completed 7Recruiting 4Terminated 2Active not recruiting 2Unknown 1Suspended 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Dermatologic 7

Conditions

Breast Neoplasms 264Carcinoma, Non-Small-Cell Lung 219Neoplasms 218Leukemia, Myeloid, Acute 193Multiple Myeloma 178Colorectal Neoplasms 175Melanoma 165Prostatic Neoplasms 163Lymphoma 145Leukemia 142Lymphoma, Non-Hodgkin 133Glioblastoma 131Pancreatic Neoplasms 127Neoplasm Metastasis 118Lung Neoplasms 118Leukemia, Lymphocytic, Chronic, B-Cell 118Ovarian Neoplasms 112Precursor Cell Lymphoblastic Leukemia-Lymphoma 106Recurrence 97Myelodysplastic Syndromes 93Hodgkin Disease 92Lymphoma, Large B-Cell, Diffuse 89Lymphoma, Follicular 89Lymphoma, Mantle-Cell 83Head and Neck Neoplasms 79Carcinoma, Renal Cell 79Brain Neoplasms 77Sarcoma 73Carcinoma, Hepatocellular 73Squamous Cell Carcinoma of Head and Neck 71

Interventions

pembrolizumab 1Photochemotherapy 1Methods 1HhAntag691 1Arsenic Trioxide 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 1/2 × Completed × Carcinoma, Basal Cell × Clear all
NCT04470726 2024-12-27

NMSC

AiViva BioPharma, Inc.

Phase 1/2 Completed
26 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT03541252 2022-04-14

Topical Laser-assisted Combination Chemotherapy for Basal Cell Carcinoma- a Clinical Study

Bispebjerg Hospital

Phase 1/2 Completed
20 enrolled 8 charts
Dermatologic

Carcinoma, Basal Cell

NCT02690948 2019-03-08

Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer

Stanford University

Phase 1/2 Completed
16 enrolled 15 charts
Dermatologic

Carcinoma, Basal Cell

NCT03569345 2018-07-10

Basal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol Mebutate

Bispebjerg Hospital

Phase 1/2 Completed
20 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT01791894 2018-06-08

ATO

Stanford University

Phase 1/2 Completed
5 enrolled 9 charts
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

NCT00403377 2015-10-01

Investigation of a Behavioral Substitute for Sunbathing

University of Massachusetts, Worcester

Phase 1/2 Completed
307 enrolled
Dermatologic

Carcinoma, Basal Cell, Melanoma, Skin Neoplasms

NCT00988455 2009-10-02

Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma With 6 Months Follow-up

Shahid Beheshti University of Medical Sciences

Phase 1/2 Completed
28 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡